MARKET

SIEN

SIEN

Sientra
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.25
0.00
0.00%
After Hours: 8.50 +0.25 +3.03% 19:02 07/30 EDT
OPEN
8.18
PREV CLOSE
8.25
HIGH
8.51
LOW
8.11
VOLUME
444.34K
TURNOVER
--
52 WEEK HIGH
9.14
52 WEEK LOW
3.210
MARKET CAP
474.55M
P/E (TTM)
-3.7050
1D
5D
1M
3M
1Y
5Y
Sientra to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
Sientra, Inc. (NASDAQ: SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Tuesday, Augus...
GlobeNewswire · 4d ago
Aesthetic Devices Market Size 2021 Explosive Factors of Revenue By Progression Status, Emerging Demands, Recent Trends, Business Opportunity, Share and Forecast To 2027
The scope of the report includes a detailed study of Global Aesthetic Devices Market with the reasons given for variations in the growth of the industry in certain regions.
Heraldkeepers · 4d ago
BRIEF-Sientra Inc - On July 16, Board Approved An Increase In Size Of Board From 7 Directors To 9 Directors
reuters.com · 07/22 21:26
Hedge Funds Have Never Been This Bullish On Sientra Inc (SIEN)
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of March 31st. The ...
Insider Monkey · 07/20 14:29
BRIEF-Sientra Announces Appointment Of Chief Financial Officer
reuters.com · 07/12 12:18
Sientra Names Andy Schmidt CFO
MT Newswires · 07/12 08:47
Stocks That Hit 52-Week Highs On Friday
    Before 10 a.m. ET on Friday, 115 companies hit new 52-week highs.
Benzinga · 07/09 16:36
Aesthetic Devices Market 2021 With Covid-19 Impact on Market Share, Size, Revenue, Latest Trends, Business Boosting Strategies, CAGR Status, Growth Opportunities and Forecast 2027
The scope of the report includes a detailed study of Global Aesthetic Devices Market with the reasons given for variations in the growth of the industry in certain regions.
Heraldkeepers · 06/29 18:13
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SIEN. Analyze the recent business situations of Sientra through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SIEN stock price target is 10.86 with a high estimate of 13.00 and a low estimate of 9.00.
EPS
Institutional Holdings
Institutions: 189
Institutional Holdings: 54.47M
% Owned: 94.69%
Shares Outstanding: 57.52M
TypeInstitutionsShares
Increased
43
6.55M
New
33
9.90M
Decreased
24
1.65M
Sold Out
15
2.37M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.70%
Healthcare Equipment & Supplies
+0.66%
Key Executives
Chairman/Executive Director
Caroline Van Hove
President/Chief Executive Officer/Director
Ronald Menezes
Chief Financial Officer
Andrew Schmidt
Chief Compliance Officer/General Counsel
Oliver Bennett
Vice President/Controller
Valerie Miller
Vice President - Research & Development
Denise Dajles
Lead Director/Independent Director
Nicholas Simon
Director
Keith Sullivan
Independent Director
Nori Ebersole
Independent Director
Irina Erenburg
Independent Director
Mary Fisher
Independent Director
Kevin O'Boyle
Independent Director
Philippe Schaison
No Data
About SIEN
Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 400 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include OPUS, Luxe, Curve, AlloX2, Dermaspan and Softspan.

Webull offers kinds of Sientra Inc stock information, including NASDAQ:SIEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SIEN stock methods without spending real money on the virtual paper trading platform.